Evaluation of the Dose Received by the Prostate With in Vivo Dosimetry in Patients Treated With Daily IGRT Associated With IMRT Using Two Repositioning Techniques for Localized Prostate Cancer
NCT ID: NCT02279693
Last Updated: 2024-02-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
3 participants
INTERVENTIONAL
2014-12-22
2019-08-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intensity Modulated Radiation Therapy for Prostate Cancer
NCT00214422
Image Guided Radiation Therapy For Prostate Cancer
NCT00433706
Intensity-modulated Radiation Therapy From 70Gy to 80Gy in Localized Prostate Cancer
NCT02974231
Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer
NCT02040610
Comparison of Radiation Therapy Regimens in Treating Patients With Localized Prostate Cancer
NCT00010244
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CBCT
cone beam computed tomography (CBCT) repositioning
CBCT
10 participants will receive a cone beam computed tomography (CBCT) repositioning
IGRT Associated With IMRT
fiducial markers
kV imaging of fiducial marker repositioning
fiducial marker (kV imaging)
10 participants will receive a kV imaging of fiducial marker repositioning.
IGRT Associated With IMRT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CBCT
10 participants will receive a cone beam computed tomography (CBCT) repositioning
fiducial marker (kV imaging)
10 participants will receive a kV imaging of fiducial marker repositioning.
IGRT Associated With IMRT
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* carcinoma of the prostate histologically confirmed
* OMS 0-1
* localized stage
* favorable, intermediate and unfavorable groups according to NCCN or D'Amico classification
* patients must have signed a written informed consent form
* patients must be affiliated to a Social Health Insurance.
Exclusion Criteria
* indication for pelvic radiation
* anticoagulant therapy
* lateral or bilateral hip replacement
* patient receiving an adult protective services
* Patient unable to comply with the required medical follow-up for geographic, social or psychological reasons
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Georges Francois Leclerc
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gilles CREHANGE, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Centre Georges François Leclerc
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Georges-François Leclerc
Dijon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014-A00122-45
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.